Friday, May 27, 2016

UPDATE 1-EU regulators back approval of Gilead's new hep C drug

May 27 (Reuters) - An advisory panel to the European drug

regulator recommended an approval for Gilead Sciences Inc's

new drug combination to treat hepatitis C.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)